Untargeted Metabolomics Reveal Pathways Associated with Neuroprotective Effect of Oxyresveratrol in SH-SY5Y Cells

Overview

Journal Sci Rep

Specialty Science

Date 2023 Nov 21

PMID 37989867

Authors

Nureesun Mahamud

Phanit Songvut

Chawanphat Muangnoi

Ratchanee Rodsiri

Winai Dahlan

Rossarin Tansawat

Affiliations

Soon will be listed here.

Abstract

Oxyresveratrol has been documented benefits for neurodegenerative disease. However, the specific molecular mechanisms and pathways involved is currently limited. This study aimed to investigate the potential neuroprotective mechanisms of oxyresveratrol using rotenone-induced human neuroblastoma SH-SY5Y cytotoxicity. Cells were divided into the following groups: control, rotenone, and oxyresveratrol pre-treated before being exposed to rotenone. Cellular assays were performed to investigate neuroprotective effects of oxyresveratrol. The results showed that 20 μM oxyresveratrol was effective in preventing rotenone-induced cell death and decreasing ROS levels in the cells. The alteration of metabolites and pathways involved in the neuroprotective activities of oxyresveratrol were further investigated using LC-QTOF-MS/MS untargeted metabolomics approach. We hypothesized that oxyresveratrol's neuroprotective effects would be associated with neurodegenerative pathways. A total of 294 metabolites were identified. 7,8-dihydrobiopterin exhibited the highest VIP scores (VIP > 3.0; p < 0.05), thus considered a biomarker in this study. Our results demonstrated that pretreatment with oxyresveratrol upregulated the level of 7,8-dihydrobiopterin compared to the positive control. Pathway analysis verified that 7,8-dihydrobiopterin was primarily associated with phenylalanine, tyrosine, and tryptophan metabolism (impact = 1, p < 0.001), serving as essential cofactors for enzymatic function in the dopamine biosynthesis pathway. In conclusion, oxyresveratrol may be benefit for the prevention of neurodegenerative diseases by increasing 7,8-dihydrobiopterin concentration.

Citing Articles

Exploring therapeutic potential of bioactive compounds against Alzheimer's and Parkinson's diseases.

Shukla R, Mishra K, Singh S 3 Biotech. 2025; 15(3):61.

PMID: 39959708 PMC: 11828772. DOI: 10.1007/s13205-025-04224-6.

Targeting Neurological Disorders with Stilbenes: Bridging the Preclinical-Clinical Gap.

Begh M, Khan J, Zehravi M, Sweilam S, Raja A, Muthukumar A Int J Biol Sci. 2024; 20(14):5474-5494.

PMID: 39494329 PMC: 11528462. DOI: 10.7150/ijbs.102032.

Identification of nitric oxide-mediated necroptosis as the predominant death route in Parkinson's disease.

Zhang T, Rui W, Sun Y, Tian Y, Li Q, Zhang Q Mol Biomed. 2024; 5(1):44.

PMID: 39443410 PMC: 11499487. DOI: 10.1186/s43556-024-00213-y.

Oxyresveratrol reduces lipopolysaccharide-induced inflammation and oxidative stress through inactivation of MAPK and NF-κB signaling in brain endothelial cells.

Zhou Y, Deng Q, Vong C, Khan H, Cheang W Biochem Biophys Rep. 2024; 40:101823.

PMID: 39290344 PMC: 11407036. DOI: 10.1016/j.bbrep.2024.101823.

Unearthing the Potential Therapeutic Effects of Oxyresveratrol Based on Intrinsic Links between Pharmacological Effects: Implications for the Gut-Liver-Brain Axis.

Zhao L, Duan Y, Li Z, Li J, Li S Pharmaceuticals (Basel). 2024; 17(8).

PMID: 39204169 PMC: 11359039. DOI: 10.3390/ph17081063.

References

van Rumund A, Pavelka L, Esselink R, Geurtz B, Wevers R, Mollenhauer B . Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase. NPJ Parkinsons Dis. 2021; 7(1):29. PMC: 7979935. DOI: 10.1038/s41531-021-00172-z. View

Chao J, Yu M, Ho Y, Wang M, Chang R . Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity. Free Radic Biol Med. 2008; 45(7):1019-26. DOI: 10.1016/j.freeradbiomed.2008.07.002. View

Beckers M, Bloem B, Verbeek M . Mechanisms of peripheral levodopa resistance in Parkinson's disease. NPJ Parkinsons Dis. 2022; 8(1):56. PMC: 9095610. DOI: 10.1038/s41531-022-00321-y. View

Prakash R, Fauzia E, Siddiqui A, Yadav S, Kumari N, Shams M . Oxidative Stress-induced Autophagy Compromises Stem Cell Viability. Stem Cells. 2022; 40(5):468-478. DOI: 10.1093/stmcls/sxac018. View

Maker G, Green T, Mullaney I, Trengove R . Untargeted Metabolomic Analysis of Rat Neuroblastoma Cells as a Model System to Study the Biochemical Effects of the Acute Administration of Methamphetamine. Metabolites. 2018; 8(2). PMC: 6027511. DOI: 10.3390/metabo8020038. View

Xie Q, Zhao H, Li N, Su L, Xu X, Hong Z . Protective effects of timosaponin BII on oxidative stress damage in PC12 cells based on metabolomics. Biomed Chromatogr. 2018; 32(10):e4321. DOI: 10.1002/bmc.4321. View

Weber J, Lamont M, Chibrikova L, Fekkes D, Vlug A, Lorenz P . Potential neuroprotective effects of oxyresveratrol against traumatic injury. Eur J Pharmacol. 2012; 680(1-3):55-62. DOI: 10.1016/j.ejphar.2012.01.036. View

Yarmohammadi F, Wallace Hayes A, Najafi N, Karimi G . The protective effect of natural compounds against rotenone-induced neurotoxicity. J Biochem Mol Toxicol. 2020; 34(12):e22605. DOI: 10.1002/jbt.22605. View

Alam M, Alam S, Shamsi A, Adnan M, Elasbali A, Abu Al-Soud W . Bax/Bcl-2 Cascade Is Regulated by the EGFR Pathway: Therapeutic Targeting of Non-Small Cell Lung Cancer. Front Oncol. 2022; 12:869672. PMC: 8990771. DOI: 10.3389/fonc.2022.869672. View

10.

Kaneko K, Hineno A, Yoshida K, Ikeda S . Increased vulnerability to rotenone-induced neurotoxicity in ceruloplasmin-deficient mice. Neurosci Lett. 2008; 446(1):56-8. DOI: 10.1016/j.neulet.2008.08.089. View

11.

Gonzalez-Sarrias A, Nunez-Sanchez M, Tomas-Barberan F, Espin J . Neuroprotective Effects of Bioavailable Polyphenol-Derived Metabolites against Oxidative Stress-Induced Cytotoxicity in Human Neuroblastoma SH-SY5Y Cells. J Agric Food Chem. 2017; 65(4):752-758. DOI: 10.1021/acs.jafc.6b04538. View

12.

Oliveira J, Gilbert S, Pinheiro M, Tiedemann A, Macedo L, Maia L . Effect of sport on health in people aged 60 years and older: a systematic review with meta-analysis. Br J Sports Med. 2022; 57(4):230-236. PMC: 9933166. DOI: 10.1136/bjsports-2022-105820. View

13.

Lo A, Guibal P, Doummar D, Rodriguez D, Hautem J, Couderc R . Single-Step Rapid Diagnosis of Dopamine and Serotonin Metabolism Disorders. ACS Omega. 2018; 2(9):5962-5972. PMC: 6044980. DOI: 10.1021/acsomega.7b01008. View

14.

Piechowska P, Zawirska-Wojtasiak R, Mildner-Szkudlarz S . Bioactive β-Carbolines in Food: A Review. Nutrients. 2019; 11(4). PMC: 6520841. DOI: 10.3390/nu11040814. View

15.

Ioghen O, Ceafalan L, Popescu B . SH-SY5Y Cell Line Models for Parkinson Disease Research-Old Practice for New Trends. J Integr Neurosci. 2023; 22(1):20. DOI: 10.31083/j.jin2201020. View

16.

Nagatsu T, Nakashima A, Ichinose H, Kobayashi K . Human tyrosine hydroxylase in Parkinson's disease and in related disorders. J Neural Transm (Vienna). 2018; 126(4):397-409. DOI: 10.1007/s00702-018-1903-3. View

17.

Flydal M, Krakenes T, Tai M, Tran M, Teigen K, Martinez A . Levalbuterol lowers the feedback inhibition by dopamine and delays misfolding and aggregation in tyrosine hydroxylase. Biochimie. 2020; 183:126-132. DOI: 10.1016/j.biochi.2020.12.002. View

18.

Aborode A, Pustake M, Awuah W, Alwerdani M, Shah P, Yarlagadda R . Targeting Oxidative Stress Mechanisms to Treat Alzheimer's and Parkinson's Disease: A Critical Review. Oxid Med Cell Longev. 2022; 2022:7934442. PMC: 9357807. DOI: 10.1155/2022/7934442. View

19.

Du D, Su Y, Shang Q, Chen C, Tang W, Zhang L . Biomimetic synthesis of L-DOPA inspired by tyrosine hydroxylase. J Inorg Biochem. 2022; 234:111878. DOI: 10.1016/j.jinorgbio.2022.111878. View

20.

Kodra D, Pousinis P, Vorkas P, Kademoglou K, Liapikos T, Pechlivanis A . Is Current Practice Adhering to Guidelines Proposed for Metabolite Identification in LC-MS Untargeted Metabolomics? A Meta-Analysis of the Literature. J Proteome Res. 2021; 21(3):590-598. DOI: 10.1021/acs.jproteome.1c00841. View